循環器ジャーナル72巻3号

2024年07月発行

特集 心房細動—予防・早期発見・治療の進化 Ⅵ.特殊な病態

デバイス植込み後のhigh rate episodeに対する戦略

著者： 石橋耕平¹

所属機関： ¹国立循環器病研究センター心臓血管内科部門不整脈科

ページ範囲：P.504 - P.509

POINT
●心臓植込み型デバイスで検出された心房細動（CIEDs-AF）は，通常の心房細動と対応が異なる．
●抗凝固療法が必要なCIEDs-AFの持続時間は不明であり，医師の裁量に委ねられている．
●CIEDs-AFの早期発見・治療には，遠隔モニタリングが有効である．

参考文献

1）Lowres N, Neubeck L, Redfern J, et al. Screening to identify unknown atrial fibrillation. A systematic review. Thromb Haemost 2013 ; 110 : 213-22.

2）Esato M, Chun YH, An Y, et al. Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation : The Fushimi AF Registry. Chest 2017 ; 152 : 1266-75.

3）Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012 ; 366 : 120-9.

4）Boriani G, Glotzer TV, Ziegler PD, et al. Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden. Heart Rhythm 2018 ; 15 : 376-83.

5）Todo K, Okazaki S, Doijiri R, et al. Atrial Fibrillation Detection and Ischemic Stroke Recurrence in Cryptogenic Stroke : A Retrospective, Multicenter, Observational Study. J Am Heart Assoc 2024 ; 13 : e031508.

6）Deshmukh A, Brown ML, Higgins E, et al. Performance of Atrial Fibrillation Detection in a New Single-Chamber ICD. Pacing Clin Electrophysiol 2016 ; 39 : 1031-7.

7）Swerdlow CD, Schsls W, Dijkman B, et al. Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators. Circulation 2000 ; 101 : 878-85.

8）Kaufman ES, Israel CW, Nair GM, et al. Positive predictive value of device-detected atrial high-rate episodes at different rates and durations : an analysis from ASSERT. Heart Rhythm 2012 ; 9 : 1241-6.

9）Assaf A, Theuns D, Sakhi R, et al. Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation : Results of the BioVAD study. Ann Noninvasive Electrocardiol 2022 ; 27 : e12960.

10）Purerfellner H, Sanders P, Sarkar S, et al. Adapting detection sensitivity based on evidence of irregular sinus arrhythmia to improve atrial fibrillation detection in insertable cardiac monitors. Europace 2018 ; 20 : f321-f8.

11）Boriani G, Glotzer TV, Santini M, et al. Device-detected atrial fibrillation and risk for stroke : an analysis of ＞10, 000 patients from the SOS AF project（Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices）. Eur Heart J 2014 ; 35 : 508-16.

12）Van Gelder IC, Healey JS, Crijns H, et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J 2017 ; 38 : 1339-44.

13）Nogami A, Kurita T, Kusano K, et al. JCS/JHRS 2021 Guideline Focused Update on Non-Pharmacotherapy of Cardiac Arrhythmias. Circ J 2022 ; 86 : 337-63.

14）Kirchhof P, Toennis T, Goette A, et al. Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. N Engl J Med 2023 ; 389 : 1167-79.

15）Healey JS, Lopes RD, Granger CB, et al. Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation. N Engl J Med 2024 ; 390 : 107-17.

16）McIntyre WF, Benz AP, Becher N, et al. Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation : A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials. Circulation 2024 ; 149 : 981-8.

17）Stein KM, Euler DE, Mehra R, et al. Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients? J Am Coll Cardiol 2002 ; 40 : 335-40.

18）Mustafa U, Dherange P, Reddy R, et al. Atrial Fibrillation Is Associated With Higher Overall Mortality in Patients With Implantable Cardioverter-Defibrillator : A Systematic Review and Meta-Analysis. J Am Heart Assoc 2018 ; 7 : e010156.

19）Cheng A, Landman SR, Stadler RW. Reasons for loss of cardiac resynchronization therapy pacing : insights from 32 844 patients. Circ Arrhythm Electrophysiol 2012 ; 5 : 884-8.

20）Nakajima I, Noda T, Kanzaski H, et al. Development of Heart Failure From Transient Atrial Fibrillation Attacks in Responders to Cardiac Resynchronization Therapy. JACC Clin Electrophysiol 2018 ; 4 : 1227-34.

21）Slotwiner D, Varma N, Akar JG, et al. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart Rhythm 2015 ; 12 : e69-100.

22）Saxon LA, Hayes DL, Gilliam FR, et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up : the ALTITUDE survival study. Circulation 2010 ; 122 : 2359-67.

23）Hindricks G, Taborsky M, Glikson M, et al. Implant-based multiparameter telemonitoring of patients with heart failure（IN-TIME） : a randomised controlled trial. Lancet 2014 ; 384 : 583-90.

24）Hindricks G, Varma N, Kacet S, et al. Daily remote monitoring of implantable cardioverter-defibrillators : insights from the pooled patient-level data from three randomized controlled trials（IN-TIME, ECOST, TRUST）. Eur Heart J 2017 ; 38 : 1749-55.

25）Mabo P, Victor F, Bazin P, et al. A randomized trial of long-term remote monitoring of pacemaker recipients（the COMPAS trial）. Eur Heart J 2012 ; 33 : 1105-11.

26）Guedon-Moreau L, Lacroix D, Sadoul N, et al. A randomized study of remote follow-up of implantable cardioverter defibrillators : safety and efficacy report of the ECOST trial. Eur Heart J 2013 ; 34 : 605-14.

27）Varma N, Piccini JP, Snell J, et al. The Relationship Between Level of Adherence to Automatic Wireless Remote Monitoring and Survival in Pacemaker and Defibrillator Patients. J Am Coll Cardiol 2015 ; 65 : 2601-10.

28）Mittal S, Piccini JP, Snell J, et al. Improved survival in patients enrolled promptly into remote monitoring following cardiac implantable electronic device implantation. J Interv Card Electrophysiol 2016 ; 46 : 129-36.